DOXYCYCLINE CAPSULES 100 MG
DOXYCYCLINE (DOXYCYCLINE HYCLATE) : 100 MG · DIN 02351234 · SANIS HEALTH INC
Health Canada status: DORMANT
What is DOXYCYCLINE CAPSULES?
DOXYCYCLINE CAPSULES 100 MG contains DOXYCYCLINE (DOXYCYCLINE HYCLATE) : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02351234, held by SANIS HEALTH INC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as dormant, status dated 23-Jul-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is DOXYCYCLINE CAPSULES used for?
Treatment of pneumonia, respiratory tract infections, genitourinary tract infections (including Chlamydia trachomatis), skin and soft tissue infections, and gastro-intestinal infections.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02351234 |
|---|---|
| Brand name | DOXYCYCLINE CAPSULES |
| Generic / active ingredient | DOXYCYCLINE (DOXYCYCLINE HYCLATE) : 100 MG |
| Manufacturer | SANIS HEALTH INC |
| Strength | 100 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J01AA02 DOXYCYCLINE |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 23-Jul-2026 |
How is it administered?
Adults: 200 mg loading dose on day 1, then 100 mg daily. Severe infections: 200 mg daily. Take with a full glass of water while upright; do not go to bed within 1-2 hours after intake.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store between 15°C and 30°C and protect from light.
How is it supplied?
Bottles of 100 capsules or 100 tablets.
Contraindications
Hypersensitivity to doxycycline or other tetracyclines; myasthenia gravis; patients taking isotretinoin.
Warnings and precautions
Risk of permanent tooth discoloration in children <8 and last trimester of pregnancy. Esophageal lesions if taken without water/upright. Clostridium difficile-associated disease (CDAD).
What can be used instead?
Other Canadian products sharing ATC code J01AA02 DOXYCYCLINE. 14 of 43 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-DOXYCYCLINE | 100 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02556928 |
| APO-DOXY CAP 100MG | 100 MG | CAPSULE | APOTEX INC | MARKETED | DIN 00740713 |
| APO-DOXY TABS 100MG | 100 MG | TABLET | APOTEX INC | MARKETED | DIN 00874256 |
| APO-DOXYCYCLINE MR | 40 MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | APOTEX INC | MARKETED | DIN 02512645 |
| APPRILON | 40 MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | GALDERMA CANADA INC | MARKETED | DIN 02375885 |
| DOXYCIN TAB 100MG | 100 MG | TABLET | LABORATOIRE RIVA INC. | MARKETED | DIN 00860751 |
| DOXYTAB | 100 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 00887064 |
| JAMP DOXYCYCLINE CAPSULES | 100 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | DIN 02528940 |
| JAMP DOXYCYCLINE TABLETS | 100 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02554372 |
| M-DOXYCYCLINE | 100 MG | TABLET | MANTRA PHARMA INC | MARKETED | DIN 02543478 |
Who else supplies DOXYCYCLINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DOXYCYCLINE appears in 306 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.